Whan In Pharm Co.,Ltd. (KRX:016580)
11,460
+190 (1.69%)
Last updated: Nov 26, 2025, 10:03 AM KST
Whan In Pharm Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 15,168 | 23,381 | 29,774 | 23,921 | 26,660 | 23,388 | Upgrade |
Depreciation & Amortization | 9,821 | 8,475 | 6,659 | 4,847 | 4,202 | 4,070 | Upgrade |
Loss (Gain) From Sale of Assets | 314.87 | 330.11 | 1,160 | 1,897 | 6.22 | 63.51 | Upgrade |
Loss (Gain) From Sale of Investments | -39.33 | -392.98 | -1,168 | 849.94 | -352.07 | -1,248 | Upgrade |
Loss (Gain) on Equity Investments | -870.84 | -1,981 | 1,006 | 201.08 | 61.86 | 31.74 | Upgrade |
Provision & Write-off of Bad Debts | 2,402 | 1,396 | 874.84 | 1,066 | 1,094 | 495.25 | Upgrade |
Other Operating Activities | 3,467 | 5,667 | 714.37 | -3,124 | -229.16 | 1,141 | Upgrade |
Change in Accounts Receivable | 9,814 | 1,088 | -7,320 | -10,221 | -56.46 | -93.64 | Upgrade |
Change in Inventory | -26,435 | -22,546 | -17,631 | -3,893 | 11.94 | -5,140 | Upgrade |
Change in Accounts Payable | -2,789 | 4,866 | 9,255 | 2,409 | 3,555 | -228.81 | Upgrade |
Change in Other Net Operating Assets | -549.56 | 411.23 | -128.37 | -1,102 | 365.9 | 275.9 | Upgrade |
Operating Cash Flow | 10,303 | 20,693 | 23,197 | 16,851 | 35,318 | 22,755 | Upgrade |
Operating Cash Flow Growth | -67.06% | -10.79% | 37.66% | -52.29% | 55.21% | -7.99% | Upgrade |
Capital Expenditures | -4,626 | -27,357 | -30,531 | -33,650 | -4,387 | -7,988 | Upgrade |
Sale of Property, Plant & Equipment | 4.35 | 3.95 | 88.74 | 80.44 | 34.75 | 14.96 | Upgrade |
Sale (Purchase) of Intangibles | -3,979 | -2,024 | -941.14 | -642.7 | -374.92 | -235.44 | Upgrade |
Sale (Purchase) of Real Estate | - | - | 153.69 | -33,466 | - | - | Upgrade |
Investment in Securities | 15,034 | 11,321 | 21,775 | 29,489 | 2,409 | 8,845 | Upgrade |
Other Investing Activities | -249.51 | -58 | 58.41 | -779.69 | 222.53 | -61.94 | Upgrade |
Investing Cash Flow | 6,366 | -18,095 | -9,432 | -38,942 | -2,122 | 603.42 | Upgrade |
Long-Term Debt Repaid | - | -465.53 | -414.47 | -549.98 | -613.78 | -607.14 | Upgrade |
Net Debt Issued (Repaid) | -521.78 | -465.53 | -414.47 | -549.98 | -613.78 | -607.14 | Upgrade |
Issuance of Common Stock | 9,503 | - | - | - | - | - | Upgrade |
Dividends Paid | -4,580 | -4,580 | -4,580 | -4,580 | -4,580 | -4,580 | Upgrade |
Other Financing Activities | 7.91 | -4.95 | -171.43 | - | - | - | Upgrade |
Financing Cash Flow | 4,409 | -5,051 | -5,166 | -5,130 | -5,194 | -5,187 | Upgrade |
Foreign Exchange Rate Adjustments | 283.17 | 233.66 | -8.58 | -59.27 | -19.77 | -78.7 | Upgrade |
Net Cash Flow | 21,361 | -2,219 | 8,591 | -27,280 | 27,982 | 18,092 | Upgrade |
Free Cash Flow | 5,677 | -6,664 | -7,334 | -16,799 | 30,931 | 14,767 | Upgrade |
Free Cash Flow Growth | - | - | - | - | 109.47% | -32.79% | Upgrade |
Free Cash Flow Margin | 2.21% | -2.57% | -3.18% | -8.44% | 17.40% | 8.60% | Upgrade |
Free Cash Flow Per Share | 366.36 | -436.48 | -480.39 | -1100.32 | 2025.98 | 967.21 | Upgrade |
Cash Interest Paid | 27.28 | 23.12 | 22.66 | 51.88 | 51.55 | 31.42 | Upgrade |
Cash Income Tax Paid | 3,234 | 5,094 | 5,009 | 8,354 | 8,107 | 7,370 | Upgrade |
Levered Free Cash Flow | -6,446 | -20,163 | -21,346 | -23,446 | 24,210 | 11,237 | Upgrade |
Unlevered Free Cash Flow | -6,429 | -20,148 | -21,332 | -23,414 | 24,242 | 11,256 | Upgrade |
Change in Working Capital | -19,960 | -16,181 | -15,824 | -12,807 | 3,876 | -5,186 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.